CG Oncology | IPO Presentation Deck | 45 slides · page 25 of 45
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.
Pitch deck · competitive_analysis · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 3/3
disclaimer 1/1 table 1/1 title 1/1
Components 3
disclaimer data headline
Tools 2
2x2 matrix slide · 70%
table/data: Comparison table of 8 clinical trials across 10 metrics including Trial, Intervention, Mechanism, RoA, Stage, Sample Size, BCG-Free Regimen, CR Any Time, CR 6 Mo, CR 12 Mo, and Safety Profile.
Comparison frame slide · 70%table/data: Comparison table of 8 clinical trials across 10 metrics including Trial, Intervention, Mechanism, RoA, Stage, Sample Size, BCG-Free Regimen, CR Any Time, CR 6 Mo, CR 12 Mo, and Safety Profile.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1